The Need for Transparency in EEG Foundation Models

Electroencephalogram (EEG) foundation models have achieved state-of-the-art clinical performance, representing a significant advancement in medicine. However, their widespread adoption and full trust from medical professionals are often hindered by their inherent opacity. The internal computations driving their predictions remain unclear, creating a barrier to clinical understanding and acceptance. This lack of transparency is a common issue with many Large Language Models (LLM) and complex AI models, especially when deployed in critical sectors where accuracy, explainability, and accountability are paramount.

For organizations evaluating the deployment of AI solutions in regulated or sensitive environments, such as hospitals or medical research facilities, the ability to interpret a model's internal workings is not just an advantage but a necessity. Data sovereignty and regulatory compliance, often ensured by self-hosted or air-gapped deployments, demand a level of control and understanding that opaque models cannot fully provide. Understanding how a model arrives at a diagnosis or prediction is essential for clinical validation and for mitigating the risks associated with automated decisions.

An Innovative Approach with Sparse Autoencoders

To address this challenge, recent research proposes the application of TopK Sparse Autoencoders (SAEs) to extract sparse feature dictionaries from the embeddings of various EEG transformers. The study examined three distinct architectures: SleepFM, REVE, and LaBraM. The goal is to make the internal representations of these models more interpretable and understandable. Through this process, it is possible to identify the latent features that the models use to process EEG information.

Extracted features are then grounded in a well-defined clinical taxonomy, including concepts such as abnormality, age, sex, and medication. This allows for benchmarking monosemanticity (the ability of a single feature to represent a unique clinical concept) and entanglement (the degree to which features are interconnected or confused) across different architectures. A notable aspect of the approach is the use of a single hyperparameter procedure, guided by an intrinsic dictionary health audit, which robustly transfers across all three examined architectures. This suggests a scalable methodology for mechanistic interpretability.

Implications for Reliability and On-Premise Deployment

The framework introduced by the research exposes critical representational failures that can significantly impact model reliability. Among these, “wrecking-ball” interventions are identified, which are interventions that, while aiming to modify a specific concept, end up collapsing global model performance. Clinical entanglements are also highlighted, such as age-pathology confounding, where it is impossible to suppress one concept without corrupting the other. These issues are particularly relevant for CTOs and infrastructure architects who must ensure the integrity and predictability of AI systems in production.

For those evaluating on-premise deployments, understanding these trade-offs and constraints is crucial. In environments where data sovereignty and regulatory compliance (such as GDPR) are absolute priorities, the ability to audit and understand model decisions is indispensable. Self-hosted or air-gapped deployments often imply greater control over hardware and software, but also demand greater responsibility in managing risks related to model opacity. AI-RADAR's research on /llm-onpremise offers analytical frameworks to evaluate these trade-offs, emphasizing how transparency is a key factor for trust and adoption in critical contexts.

Towards Physiological Control and Deeper Understanding

A particularly promising aspect of this work is the introduction of a spectral decoder. This innovative tool allows latent interventions to be mapped directly to the amplitude spectrum, thereby translating the model's internal manipulations into physiologically interpretable frequency signatures. For example, the suppression of pathological slow-waves and the restoration of the alpha-band were observed, providing a clear correlation between model operations and underlying biological phenomena. This ability to translate model “decisions” into concrete medical terms is a significant step forward in building more reliable and clinically useful AI systems.

The possibility of understanding and, in the future, selectively controlling the concepts represented within EEG foundation models opens new avenues for targeted fine-tuning and the development of responsible AI. For technical decision-makers, investing in tools and methodologies that enhance mechanistic interpretability means building more resilient, secure, and, above all, trustworthy AI infrastructures, especially in sectors where human or algorithmic error can have severe consequences.